A detailed history of Wells Fargo & Company transactions in Axogen, Inc. stock. As of the latest transaction made, Wells Fargo & Company holds 26,007 shares of AXGN stock, worth $346,933. This represents 0.0% of its overall portfolio holdings.

Number of Shares
26,007
Previous 47,807 45.6%
Holding current value
$346,933
Previous $346,000 5.2%
% of portfolio
0.0%
Previous 0.0%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

SELL
$7.52 - $14.69 $163,936 - $320,242
-21,800 Reduced 45.6%
26,007 $364,000
Q2 2024

Aug 13, 2024

SELL
$5.67 - $8.06 $14,050 - $19,972
-2,478 Reduced 4.93%
47,807 $346,000
Q1 2024

May 10, 2024

BUY
$6.63 - $10.69 $67,897 - $109,476
10,241 Added 25.57%
50,285 $405,000
Q4 2023

Feb 09, 2024

BUY
$3.61 - $7.76 $12,266 - $26,368
3,398 Added 9.27%
40,044 $273,000
Q3 2023

Nov 13, 2023

SELL
$4.68 - $9.26 $157,116 - $310,876
-33,572 Reduced 47.81%
36,646 $183,000
Q2 2023

Aug 15, 2023

BUY
$8.5 - $10.38 $71,740 - $87,607
8,440 Added 13.66%
70,218 $641,000
Q1 2023

May 12, 2023

BUY
$7.53 - $10.95 $58,711 - $85,377
7,797 Added 14.44%
61,778 $583,000
Q4 2022

Feb 13, 2023

SELL
$9.44 - $13.09 $28 - $39
-3 Reduced 0.01%
53,981 $538,000
Q3 2022

Nov 14, 2022

SELL
$8.14 - $12.25 $3,231 - $4,863
-397 Reduced 0.73%
53,984 $644,000
Q2 2022

Aug 12, 2022

SELL
$6.99 - $10.0 $150,557 - $215,390
-21,539 Reduced 28.37%
54,381 $445,000
Q1 2022

May 16, 2022

SELL
$7.26 - $10.7 $111,985 - $165,047
-15,425 Reduced 16.89%
75,920 $603,000
Q4 2021

Feb 14, 2022

SELL
$8.8 - $16.0 $223,520 - $406,400
-25,400 Reduced 21.76%
91,345 $855,000
Q3 2021

Nov 15, 2021

BUY
$15.23 - $21.72 $262,900 - $374,930
17,262 Added 17.35%
116,745 $1.84 Million
Q2 2021

Aug 16, 2021

BUY
$17.8 - $23.5 $369,065 - $487,249
20,734 Added 26.33%
99,483 $2.15 Million
Q1 2021

May 13, 2021

SELL
$17.18 - $22.6 $1 Million - $1.32 Million
-58,417 Reduced 42.59%
78,749 $1.6 Million
Q4 2020

Feb 09, 2021

BUY
$11.5 - $17.96 $15,019 - $23,455
1,306 Added 0.96%
137,166 $2.46 Million
Q3 2020

Nov 05, 2020

SELL
$10.62 - $13.12 $445,859 - $550,816
-41,983 Reduced 23.61%
135,860 $1.58 Million
Q2 2020

Aug 13, 2020

BUY
$7.35 - $10.81 $1.15 Million - $1.7 Million
157,112 Added 757.86%
177,843 $1.64 Million
Q1 2020

May 14, 2020

BUY
$8.38 - $17.34 $173,725 - $359,475
20,731 New
20,731 $215,000

Others Institutions Holding AXGN

About Axogen, Inc.


  • Ticker AXGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 42,283,700
  • Market Cap $564M
  • Description
  • AxoGen, Inc., together with its subsidiaries, develops and markets surgical solutions for physical damage or transection to peripheral nerves. The company's products include Avance Nerve Graft, a biologically active off-the-shelf processed human nerve allograft for bridging severed nerves without the comorbidities associated with a second surgic...
More about AXGN
Track This Portfolio

Track Wells Fargo & Company Portfolio

Follow Wells Fargo & Company and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wells Fargo & Company, based on Form 13F filings with the SEC.

News

Stay updated on Wells Fargo & Company with notifications on news.